Renal Dysfunction, Metabolic Syndrome and Cardiovascular Disease Mortality
Background. Renal disease is commonly described as a complication of metabolic syndrome (MetS) but some recent studies suggest that Chronic Kidney disease (CKD) may actually antecede MetS. Few studies have explored the predictive utility of co-clustering CKD with MetS for cardiovascular disease (CVD...
Saved in:
Main Authors: | David Martins, Chizobam Ani, Deyu Pan, Omolola Ogunyemi, Keith Norris |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Journal of Nutrition and Metabolism |
Online Access: | http://dx.doi.org/10.1155/2010/167162 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
by: Yifei Cao, et al.
Published: (2025-01-01) -
Insulin resistance surrogates are associated with all-cause mortality and cardiovascular mortality in population with metabolic syndrome: a retrospective cohort study of NHANES
by: Jinhao Liao, et al.
Published: (2025-02-01) -
Metabolic Syndrome, Chronic Kidney, and Cardiovascular Diseases: Role of Adipokines
by: Manfredi Tesauro, et al.
Published: (2011-01-01) -
Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality
by: Rosa Oh, et al.
Published: (2025-01-01) -
The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease
by: Anna E. Płatek, et al.
Published: (2023-09-01)